CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 634286-634401 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"During the first week subjects qualified by symptom scores, then entered the one-week treatment period with ZEPHYR.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T81409","span":{"begin":0,"end":115},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T81409","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T44","span":{"begin":0,"end":115},"obj":"Sentence"}],"attributes":[{"subj":"T44","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#9893ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#a7ec93"}]}]}}